The antagonism of hippocampal and cortical afterdischarge by SC-13504, a new anticonvulsant.
D000818:Animals; D000927:Anticonvulsants / Q000008:administration & dosage / Q000494:pharmacology*; D001143:Arousal / Q000187:drug effects; D001522:Behavior, Animal / Q000187:drug effects; D001555:Benzene Derivatives / Q000008:administration & dosage / Q000494:pharmacology; D002415:Cats; D002540:Cerebral Cortex / Q000187:drug effects*; D003864:Depression, Chemical; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D004567:Electrodes, Implanted; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects*; D008297:Male; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D010879:Piperazines / Q000008:administration & dosage / Q000494:pharmacology*; D011725:Pyridines / Q000008:administration & dosage / Q000494:pharmacology; D013238:Stereotaxic Techniques; D013329:Structure-Activity Relationship; D013788:Thalamus / Q000187:drug effects
D000927:Anticonvulsants; D001555:Benzene Derivatives; D010879:Piperazines; D011725:Pyridines; D010672:Phenytoin; C006249:ropizine; D010634:Phenobarbital